HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Bacterial Infections (Bacterial Infection)

Subscribe to New Research on Bacterial Infections

Share|Follow on Twitter

Infections by bacteria, general or unspecified.

Also Known As:

Bacterial Infection; Infections, Bacterial; Infection, Bacterial

Networked: 6809 relevant articles (399 outcomes, 574 trials/studies) for this Disease, Comments

Relationship Network

Disease Context: Research Results

Bacterial Infections and Mycoses
- Bacterial Infections: 6809

Related Diseases

1.	Infection
2.	Neoplasms (Cancer)
3.	Hemorrhage
4.	Neutropenia
5.	Pneumonia (Pneumonitis)

Experts

1.	Roberts, Jenny R: 10 articles (11/2008 - 11/2002)
2.	Antonini, James M: 10 articles (11/2008 - 11/2002)
3.	Müller, Beat: 10 articles (09/2008 - 12/2003)
4.	Christ-Crain, Mirjam: 8 articles (09/2008 - 02/2004)
5.	Akira, Shizuo: 6 articles (03/2010 - 12/2002)
6.	Kinoshita, Manabu: 6 articles (10/2008 - 10/2002)
7.	Nizet, Victor: 6 articles (06/2008 - 01/2003)
8.	Slomiany, Bronislaw L: 6 articles (04/2006 - 12/2003)
9.	Slomiany, Amalia: 6 articles (04/2006 - 12/2003)
10.	Chastre, Jean: 5 articles (02/2010 - 02/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Bacterial Infections:

1.	Anti-Bacterial Agents (Antibiotics)IBA 08/01/2008 - "This study suggests that GSPBRT-PCR is very useful for the rapid and accurate diagnosis of bacterial infection and that it can have an important impact on the current inappropriate and unnecessary use of antibiotics in the treatment of newborns." 08/01/1988 - "A significantly greater proportion (4.5%) of subsequent bacterial infections occurred in infants who received parenteral antibiotics (p = 0.01), and especially in a subgroup who received parenteral antibiotics for 5 or more days (11%, p less than 0.001). " 08/01/1996 - "Treatment of bacterial infections has become more effective with the advent of broad-spectrum antibiotics; however, the dreadful emergence of polyresistant strains may be a serious problem in the near future. " 04/01/1991 - "Empirical treatment with a combination of antibiotics has been shown in comparative studies to be effective in initial management of the febrile neutropenic patient: continuing studies are evaluating the role of monotherapy and of different antibiotic combinations, particularly in the light of changing patterns of bacterial infections. " 09/13/2005 - "Many antibiotics that were formerly effective in combating bacterial infections in hospital patients are no longer effective because of the evolution of resistant strains, which compromises medical care worldwide. " Order ALL the reference details at left...
2.	Ciprofloxacin (Cipro)FDA LinkGeneric 03/01/1991 - "Ciprofloxacin appears to be effective for preventing bacterial infections in neutropenic patients. " 12/11/1987 - "Prolonged administration of ciprofloxacin turned out to be safe and effective in preventing serious aerobic bacterial infections during the first three months after BMT." 09/01/2008 - "Singh et al. from Chandigarh and New Delhi for their original paper: "Efficacy of indigenously developed single vial kit preparation of (99m)Tc-ciprofloxacin in the detection of bacterial infection-An Indian experience" and to Dr. A. " 01/01/2003 - "[Clinical efficacy of ciprofloxacin 0.3%9 (Ciloxan) in the treatment of bacterial infections of the external eye segment]" 04/01/1989 - "Efficacy of ciprofloxacin in the treatment of various bacterial infections." Order ALL the reference details at left...
3.	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 10/01/1983 - "Ceftriaxone given in a 24-hourly regimen is convenient and highly effective in serious bacterial infections in children and is without significant toxicity." 05/01/1997 - "Once daily infusion of ceftriaxone therefore seems to be effective in the treatment of severe bacterial infections in Chinese patients." 11/01/1984 - "Ceftriaxone (Ro 13-9904, CTRX) was evaluated in 20 children with a suspicion of bacterial infections, 18 were shown to be effective (efficacy rate, 90%). " 11/01/1996 - "Ceftriaxone may be useful in the treatment of bacterial infections in horses. " 03/01/1982 - "Our findings suggest that ceftriaxone is a safe and effective antibiotic for therapy of serious bacterial infections." Order ALL the reference details at left...
4.	Norfloxacin FDA Link 06/15/1992 - "Norfloxacin appears to be an effective and relatively safe agent for the treatment of bacterial infections of the eyelids or conjunctiva, or both. " 01/01/1992 - "Norfloxacin appears to be an effective and relatively safe agent for the treatment of bacterial infections of the lids and/or conjunctiva. " 05/01/1992 - "The aim of the study has been to assess if intermittent treatment with norfloxacin could be able to maintain selective intestinal decontamination in cirrhotic patients in order to prevent bacterial infections. " 04/01/2009 - "However, treatment should be recommended with caution in individuals with poor liver function who do not receive norfloxacin prophylaxis for SBP, since it increases the risk of bacterial infections." 08/01/1999 - "Three bacterial infections in patients from Group I, 3 from Group II patients receiving norfloxacin and 16 from Group II patients not receiving norfloxacin were recorded (p<0.05). " Order ALL the reference details at left...
5.	Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)FDA LinkGeneric 12/24/1992 - "The time to a first bacterial infection was significantly greater for those assigned to trimethoprim-sulfamethoxazole (P = 0.017). " 04/01/1990 - "Several trials showed that cotrimoxazole was effective for the prevention of bacterial infection: thus, this antimicrobial can be used as long-term and continuous prophylaxia. " 08/01/1991 - "Prophylactic co-trimoxazole was effective in reducing the frequency of bacterial infections. " 06/01/1998 - "In conclusion, the results of the study suggest that TMP-SMX appears to be a valuable alternative to P-S, in particular in patients with opportunistic bacterial infections." 06/01/1996 - "Bacterial infection during the 3-month study period occurred in 11 control patients but in only 2 patients assigned TMP-SMX (P = 0.004). " Order ALL the reference details at left...
6.	VaccinesIBA 09/01/1985 - "Since vaccines effective against the likely major pathogens in the youngest children are not available, the acute respiratory infection control programs designed by the World Health Organization are based on simple schemes to classify illness according to severity and to treat bacterial infections early, thus preventing severe complications. " 10/26/2004 - "The lipidated vaccines, but not the nonlipidated vaccines, were able to mediate protection against viral or bacterial infection and mediate prophylactic and therapeutic anticancer activity. " 03/01/2009 - "In the future, it is anticipated that safe and effective vaccines will be developed against a number of other viral and bacterial infections as well as fungal and protozoan diseases." 06/01/2007 - "Intranasal vaccines for protection against respiratory and systemic bacterial infections." 11/02/2009 - "The importance of interactions between viral and bacterial infection and the role of new vaccines need to be clarified. " Order ALL the reference details at left...
7.	Ofloxacin (Levofloxacin)FDA LinkGeneric 01/01/2002 - "Levofloxacin therefore offers a unique combination of documented efficacy and tolerability, and provides an important option for the treatment of bacterial infections." 06/01/2009 - "CONCLUSION: Intravenous levofloxacin with a dose of 500 mg once a day is effective and safe in treating bacterial infections with low adverse reactions." 06/01/2009 - "[The clinical efficacy and safety of intravenous levofloxacin in the treatment of 4888 patients with bacterial infections: a multi-center trial]" 06/01/2009 - "OBJECTIVE: To evaluate the clinical efficiency and safety of intravenous levofloxacin in the treatment of bacterial infections at a dose of 500 mg once a day. " 01/01/2009 - "DISCUSSION: Ofloxacin is a broad-spectrum synthetic fluoroquinolone used for a wide variety of bacterial infections. " Order ALL the reference details at left...
8.	Intravenous Immunoglobulins (IVIG)FDA Link 03/01/1993 - "In addition, the current studies do not establish the efficacy of IVIg for either treating or preventing neonatal bacterial infections. " 11/01/2006 - "[Efficacy of intravenous immunoglobulins in bacterial infections]" 07/01/1994 - "IVIG therapy may also reduce the mortality and incidence of bacterial infections in adults but further studies are required. " 06/01/1994 - "In patients who received placebo during the original study, the rate of serious bacterial infections was significantly lower after change to open label IVIG (estimated 15.8 fewer episodes/100 patient years; 95% confidence interval, 3.2 to 28.5; P = 0.014). " 04/01/1991 - "In both studies, serious bacterial infections were considerably reduced by IVIg. " Order ALL the reference details at left...
9.	AntibodiesIBA 01/01/1998 - "These results suggest that antibodies in low-heat skim milk, which still have reactivity to exogenous or indigenous bacteria, may contribute to the protective effects against bacterial infection." 01/01/2005 - "Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies." 03/01/1990 - "Interestingly, the protection against the bacterial infection was accompanied by only a minor increase in specific serum antibodies against F5'EP-Sm. " 10/12/1995 - "The detection and quantitation of anti-LPS antibodies has formed the basis of classical and more recent serological studies of major bacterial infections." 05/01/1993 - "Understanding the role of antibodies might be of interest in the study of allergic processes exacerbated by bacterial infections." Order ALL the reference details at left...
10.	Immunoglobulins (Immunoglobulin)IBA 02/01/1997 - "The efficacy of intravenous immunoglobulin (i.v.IG) is questionable because the prophylactic and therapeutic administration of i.v.IG fails to reduce the incidence of bacterial infections or affect the overall survival rate. " 12/01/1991 - "Intravenous gamma immunoglobulin demonstrated to be effective in preventing bacterial infections and decreasing the number of hospitalizations in a subgroup of children infected with HIV." 06/01/1994 - "Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. " 07/01/1983 - "Efficacy of intravenous immunoglobulin preparations against viral and bacterial infections in mouse protection tests." 01/01/1980 - "[Therapy with immunoglobulins with special regard to the problem of the efficacy of intravenously applied gammaglobulin in bacterial infections]" Order ALL the reference details at left...

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 11/01/2005 - "Development of therapeutic standards in bacterial infections on the basis of pharmacoeconomic analyses and clinical studies determining effectiveness and safety of therapy allows for more rational pharmacotherapy. " 11/01/2005 - "Development of therapeutic standards in bacterial infections on the basis of pharmacoeconomic analyses and clinical studies determining effectiveness and safety of therapy allows for more rational pharmacotherapy. " 01/08/1979 - "[Prospects for bacteriological studies and chemotherapy of bacterial infections]" 10/01/2009 - "Toward the goal of validating RecA as a novel target in the chemotherapy of bacterial infections, the authors have screened 35,780 small molecules against RecA. " 07/01/2009 - "Complications of chemotherapy, such as appearance of multidrug resistance, have persuaded researchers to consider phage therapy as a new method to combat bacterial infections. " Order ALL the reference details at left...
2.	Transplants (Transplant) 04/01/1985 - "Two patients had bacterial infections during the period of study, and one patient experienced a short-lived readily reversible rejection of a corneal transplant. " 04/01/2009 - "Early bacterial infection had a negative effect on survival for adults and the median day of development was 10 days after transplant, suggesting that the prevention of bacterial infection in the very early post-UCBT phase is important." 04/01/2009 - "Multivariate analysis identified older age group (6-10, and 11-15 years versus 0-5 years of age) at transplant (HR = 2.0 and 2.7, CI, 1.1-3.5 and 1.4-4.9; P = .020 and .002, respectively) as an independent risk factor of early bacterial infection for children. " 03/01/2009 - "Prevalence of cutaneous bacterial infections and nasal carriage of Staphylococcus aureus in recipients of renal transplants." 02/01/2009 - "Relative frequencies of different types of infections (bacterial, viral, fungal and parasitic) were relatively constant, both during early and late periods following transplant. " Order ALL the reference details at left...
3.	Antibiotic Prophylaxis 06/21/2005 - "Trials have shown the efficacy of antibiotic prophylaxis in decreasing the incidence of bacterial infections but not in reducing mortality rates. " 01/01/2005 - "Trials have shown the efficacy of antibiotic prophylaxis in decreasing the incidence of bacterial infections, but not in reducing mortality rates. " 02/01/2003 - "Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials." 10/15/2006 - "New evidence shows that antibiotic prophylaxis in neutropenic patients reduces mortality, febrile episodes, and bacterial infections. " 10/01/2006 - "On multivariate analysis, antibiotic prophylaxis (relative hazard: 0.248, 95% confidence interval (CI): 0.067-0.919, p=0.037) and bacterial infection (relative hazard: 3.901, 95% CI: 1.053-14.448, p=0.042) were two independent determinants of early rebleeding. " Order ALL the reference details at left...
4.	Homologous Transplantation (Allograft) 12/01/2008 - "CONCLUSIONS: This study failed to find a higher rate of deep bacterial infection in ACL reconstructions when allograft tissue was used. " 06/01/1993 - "It appears, from this study, that rejection of the lung allograft results in alterations in BAL lymphocyte phenotypes and functions that differ from those associated with bacterial infection. " 05/01/2008 - "Bacterial infections are common in the perioperative period of solid organ allograft recipients in the clinic, and correlations between bacterial infections and acute allograft rejection have been reported. " 11/01/2005 - "This method of processing appears to be associated with a very low risk of allograft-related bacterial infection." 07/01/2005 - "The antibiotic permeable cryopreserved homograft has proven to be resistant to biofilm bacterial infection." Order ALL the reference details at left...
5.	Cardiopulmonary Resuscitation (CPR) 02/01/1991 - "These findings indicate that CPR is useful for the treatment of bacterial infections in children." 02/01/1991 - "The data indicate that CPR is safe and effective, when used in children with susceptible bacterial infections." 02/01/1991 - "3. Clinical results Evaluation of clinical effects of CPR on various types of bacterial infections was conducted in 56 subjects, excluding 3 subjects who had diseases which were excluded from the study. " 10/01/2001 - "OBJECTIVE: To compare the diagnostic performance of PCT in the early detection of invasive bacterial infection in infants with that of CPR. " 04/01/2001 - "Therefore, an increase in CPR activity may facilitate rapid inactivation of these inflammatory mediators generated at the site of bacterial infection. " Order ALL the reference details at left...

blog comments powered by Disqus

TREATMENT OPTIONS
for Bacterial Infections,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 399 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>